2011
DOI: 10.1016/j.otsr.2011.03.019
|View full text |Cite
|
Sign up to set email alerts
|

Calcitonin use in giant cell bone tumors

Abstract: Level 4.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2013
2013
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 11 publications
(2 citation statements)
references
References 32 publications
0
2
0
Order By: Relevance
“… 10 , 11 Bone defects can be supplemented with polymethylmethacrylate (PMMA) cement, autograft, allograft or bone substitute. 12 In addition, treatment can be enhanced with the use of monoclonal antibody, 13 calcitonin, 14 and bisphosphonates. 15 However, it should be noted that the effectiveness of these methods in the treatment and prevention of recurrence is still under discussion and there is no gold standard for treating GCT.…”
Section: Discussionmentioning
confidence: 99%
“… 10 , 11 Bone defects can be supplemented with polymethylmethacrylate (PMMA) cement, autograft, allograft or bone substitute. 12 In addition, treatment can be enhanced with the use of monoclonal antibody, 13 calcitonin, 14 and bisphosphonates. 15 However, it should be noted that the effectiveness of these methods in the treatment and prevention of recurrence is still under discussion and there is no gold standard for treating GCT.…”
Section: Discussionmentioning
confidence: 99%
“…However, an improvement in outcomes has not been clearly elucidated [ 72 ]. Calcitonin has also been used as adjuvant but has not been shown to be effective [ 73 ].…”
Section: Surgical Treatmentmentioning
confidence: 99%